Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult

NCT06099613 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

EyeGene Inc.